Ask a Question

User bowhen44

Member for: 2 years (since Jan 26, 2023)
Type: Registered user
Full name:
Location:
Website: https://en.wikipedia.org/wiki/Ketorolac
About: Performance regarding Alpelisib + Ruxolitinib Compared with Real-World Common Therapy Among Patients with HR+, HER2-, PIK3CA-Mutated Breast Cancer

Activity by bowhen44

Score: 100 points (ranked #11)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for bowhen44

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...